Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Mueller

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Diagnostic Microbiology and Infectious Disease|February 21, 2015
How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?Janattul-Ain Jamal, Bruce A Mueller, Gordon Y S Choi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Trace element removal during in vitro and in vivo continuous haemodialysisMariann D Churchwell, Deborah A Pasko, Imad F Btaiche, et al.
Pediatric Nephrology (Berlin, Germany)|January 22, 2009
Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case seriesDeborah A Pasko, Mariann D Churchwell, Imad F Btaiche, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 18, 2023
Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro ResultsSoo M Jang, Jeng-Jong Shieh, Ivan R Riley, et al.
The International Journal of Artificial Organs|December 25, 2013
In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patientsJames M Stevenson, Michael Heung, A Mary Vilay, et al.
The Annals of Pharmacotherapy|June 21, 2018
β-Lactams: The Competing Priorities of Nephrotoxicity, Neurotoxicity, and StewardshipErin F Barreto, Bruce A Mueller, Sandra L Kane-Gill, et al.
Pharmacotherapy|September 28, 2005
Pharmacokinetics of intravenously administered levofloxacin in men and womenBrian R Overholser, Michael B Kays, Seema Lagvankar, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2021
Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysisKatherine N Gharibian, Susan J Lewis, Michael Heung, et al.
Basic & Clinical Pharmacology & Toxicology|May 27, 2016
Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic PolymorphismsJian Shi, Xinwen Wang, Rachel F Eyler, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 17, 2009
Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patientsMeri Kay Scott, Niyati A Shah, A Mary Vilay, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Diagnostic Microbiology and Infectious Disease|February 21, 2015
How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?Janattul-Ain Jamal, Bruce A Mueller, Gordon Y S Choi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Trace element removal during in vitro and in vivo continuous haemodialysisMariann D Churchwell, Deborah A Pasko, Imad F Btaiche, et al.
Pediatric Nephrology (Berlin, Germany)|January 22, 2009
Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case seriesDeborah A Pasko, Mariann D Churchwell, Imad F Btaiche, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 18, 2023
Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro ResultsSoo M Jang, Jeng-Jong Shieh, Ivan R Riley, et al.
The International Journal of Artificial Organs|December 25, 2013
In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patientsJames M Stevenson, Michael Heung, A Mary Vilay, et al.
The Annals of Pharmacotherapy|June 21, 2018
β-Lactams: The Competing Priorities of Nephrotoxicity, Neurotoxicity, and StewardshipErin F Barreto, Bruce A Mueller, Sandra L Kane-Gill, et al.
Pharmacotherapy|September 28, 2005
Pharmacokinetics of intravenously administered levofloxacin in men and womenBrian R Overholser, Michael B Kays, Seema Lagvankar, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2021
Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysisKatherine N Gharibian, Susan J Lewis, Michael Heung, et al.
Basic & Clinical Pharmacology & Toxicology|May 27, 2016
Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic PolymorphismsJian Shi, Xinwen Wang, Rachel F Eyler, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 17, 2009
Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patientsMeri Kay Scott, Niyati A Shah, A Mary Vilay, et al.
Pageof 10